Home  >  Products  >  EIF4G2 (eukaryotic translation initiation factor 4 gamma, 2) Blocking Peptide (100ug)
EIF4G2 (eukaryotic translation initiation factor 4 gamma, 2) Blocking Peptide (100ug)

EIF4G2 (eukaryotic translation initiation factor 4 gamma, 2) Blocking Peptide (100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-EIF4G2 antibody (Catalogue #: ARP40361_P050) made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Presku: AAP40361
Size: 100 ug
Weight: 39kDa
Gene: 1982
Format: Lyophilized powder
Target: Translation initiation is mediated by specific recognition of the cap structure by eukaryotic translation initiation factor 4F (eIF4F), which is a cap binding protein complex that consists of three subunits: eIF4A, eIF4E and eIF4G. EIF4G2 shares similarity with the C-terminal region of eIF4G that contains the binding sites for eIF4A and eIF3; eIF4G, in addition, contains a binding site for eIF4E at the N-terminus. Unlike eIF4G, which supports cap-dependent and independent translation, EIF4G2 functions as a general repressor of translation by forming translationally inactive complexes.
See Full Product Listings >